Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

WARNECKE STEVE B

2. Date of Event Requiring Statement (MM/DD/YYYY) 6/16/2014

3. Issuer Name and Ticker or Trading Symbol

Fona, Inc. [FNAM]

(Last) (First) (Middle)

1026 ANACONDA DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Chief Financial Officer, TSD /

(Street)

CASTLE ROCK, CO 80108

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	732000	I	See Footnote ⁽¹⁾ ⁽⁴⁾

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security
Call Option (right to buy)	⁽²⁾	⁽²⁾	Common Stock	2252233	$0.009	I	See Footnote ⁽¹⁾ ⁽⁴⁾
Call Option (right to buy)	⁽³⁾	⁽³⁾	Common Stock	3222950	$0.003	I	See Footnote ⁽¹⁾ ⁽⁴⁾

Explanation of Responses:
( 1)	Reporting Person is the Chief Executive Officer of Evolutionary Genomics, Inc. ("EG") and holder of 782,539 shares of the Series B-2 Preferred Stock, representing 64.2% of the issued and outstanding shares of preferred stock of EG, and 1,028,280 shares of commons stock, or 27.4% of the issued and outstanding common stock of EG. One June 4, 2014, EG acquired 732,000 shares of common stock of Fona, Inc. and options to purchase an additional 5,475,183 shares of common stock.
( 2)	On June 6, 2014, EG entered into Securities Purchase Option Agreement with Nick Boosalis, Desfaire, Inc., and The Boosalis Group, Inc. for the purchase of a call option (the "Boosalis Option") to acquire an aggregate of 2,252,233 shares of common stock of Fona, Inc. at an aggregate purchase price of $30,000. The Option is exercisable on the date of termination of the Agreement and Plan of Merger (the "Merger Agreement") entered into as of June 4, 2014 between Fona, Inc., EG and the parties listed thereto for a period of six (6) months after the date of termination. In the event that the mergers contemplated by the Merger Agreement are consummated, the Option shall expire worthless.
( 3)	On June 6, 2014, EG entered into a Securities Purchase Agreement with Michael Friess and Sanford Schwartz for the purchase of an aggregate of 732,000 shares of common stock of Fona, Inc. for an aggregate purchase price of $145,000 and a call option (the "Friess-Schwartz Option") to purchase an additional 3,222,950 shares of Common Stock at an aggregate purchase price of $10,000. The Option is exercisable on the date of termination of the Merger Agreement for a period of six (6) months from the date of termination. In the event that the mergers contemplated by the Merger Agreement are consummated, the Option shall expire worthless.
( 4)	Reporting Person disclaims beneficial ownership of the reported securities owned by EG except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for any purpose.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
WARNECKE STEVE B 1026 ANACONDA DRIVE CASTLE ROCK, CO 80108	X		Chief Financial Officer, TSD

Signatures
/s/ Steve Warnecke		6/16/2014
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.